(S1 (S (NP (NP (NP (NN Suppression)) (CC and) (NP (NN re-expression))) (PP (IN of) (NP (VBN transformed) (NN phenotype))) (PP (IN in) (NP (NP (NNS hybrids)) (PP (IN of) (NP (NP (JJ HA-ras-1-transformed) (NN rat-1) (NNS cells)) (CC and) (NP (JJ early-passage) (NN rat) (JJ embryonic) (NNS fibroblasts)))))) (. .))))
(S1 (S (S (NP (NP (NN Rat-1) (NNS cells)) (SBAR (WHNP (WDT which)) (S (VP (VBD had) (VP (VBN been) (VP (VBN transformed) (PP (IN with) (NP (NP (DT the) (VBN activated) (NN Ha-ras-1) (NN gene)) (PP (IN from) (NP (JJ human) (NN EJ) (NN bladder) (NN carcinoma) (NNS cells))))))))))) (VP (VBD were) (VP (VBN fused) (PP (IN with) (NP (JJ diploid) (JJ embryonic) (NN rat) (NNS fibroblasts)))))) (. .)))
(S1 (S (S (NP (CD Four) (VBN selected) (NN cell) (NNS hybrids)) (VP (VBD expressed) (NP (NP (DT the) (JJ human) (NN transforming) (NN gene)) (NN product) (NN p21)) (PP (IN at) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (QP (CD 10) (TO to) (CD 30)) (NN %)) (VP (VBN compared) (PP (TO to) (NP (NP (CD 100) (NN %)) (PP (IN in) (NP (DT the) (VBN transformed) (JJ parental) (NNS cells)))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN hybrid) (NNS cells)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD exhibited) (NP (NP (JJ normal) (NN morphology)) (, ,) (NP (NP (NN anchorage) (NN requirement)) (PP (IN for) (NP (NN proliferation)))) (, ,) (CC and) (NP (NP (ADJP (RB largely) (VBN extended)) (NN latency) (NNS periods)) (PP (IN of) (NP (NN tumorigenicity))))) (PP (IN in) (NP (JJ newborn) (NNS rats))))) (. .)))
(S1 (S (S (NP (JJ Tumorigenic) (NN hybrid) (NNS derivatives)) (VP (VBD contained) (NP (NP (JJR lower) (NNS numbers)) (PP (IN of) (NP (NNS chromosomes)))) (PP (IN than) (NP (DT the) (JJ tetraploid) (JJ parental) (NNS hybrids))))) (. .)))
(S1 (S (S (NP (NP (NN DNA)) (PP (IN of) (NP (DT the) (JJ non-tumorigenic) (NN cell) (NNS hybrids)))) (VP (VBD transformed) (NP (NN Rat-1) (NNS cells)) (PP (TO to) (NP (JJ anchorage-independent) (NN proliferation))) (SBAR (IN as) (S (VP (VBN expected) (PP (IN for) (NP (NP (DT the) (NN transforming) (JJ human) (NN Ha-ras) (NN gene)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (NN donor) (NN DNA))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (S (NP (NP (DT the) (NN transforming) (NNS properties)) (PP (IN of) (NP (NP (DT the) (VBN activated) (NN Ha-ras) (NN gene)) (PP (IN in) (NP (NN Rat-1) (NNS cells)))))) (VP (MD can) (VP (VB be) (VP (VBN suppressed) (PP (IN at) (NP (DT the) (JJ post-translational) (NN level))) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NN genome))) (PP (IN from) (NP (JJ diploid) (JJ embryonic) (NN rat) (NNS fibroblasts))))))))) (CC but) (S (NP (NP (JJ additional) (NNS controls)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN transforming) (NN gene)))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB exist))))))))))) (. .)))
(S1 (S (S (NP (JJ Normal) (NNS cells)) (VP (VBP contain) (NP (NP (NN suppressor) (NN gene-LRB-s-RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBP safeguard) (NP (DT these) (NNS cells)) (PP (IN against) (NP (NN transformation))) (PP (IN by) (NP (NP (DT the) (NN product)) (PP (IN of) (NP (DT the) (NN transforming) (NN Ha-ras-1) (NN oncogene))))))))))) (. .)))
